Related Experiment Video
Updated: Jun 3, 2026
12:12
Transformation of Probiotic Yeast and Their Recovery from Gastrointestinal Immune Tissues Following Oral Gavage in Mice
Published on: February 8, 2016
Enabling Clinical Translation of Oral Probiotics Through Formulation Engineering and Scalable Manufacturing
Junyu Liu1, Yuqi Zhang1, Yuqing Huang1
1Institute of Biopharmaceutical and Health Engineering, Shenzhen International Graduate School, Tsinghua University, Shenzhen, China.
Biotechnology Journal
|June 2, 2026
Summary
Oral probiotics offer therapeutic potential but face challenges in survival and colonization. Advanced formulations and engineering are key to enhancing their efficacy for various diseases.
Area of Science:
- Microbiology
- Biotechnology
- Gastroenterology
Background:
- Oral probiotics show promise for health modulation and disease prevention.
- Current limitations include gastrointestinal degradation, poor colonization, and an oversimplified view of strain survival impacting efficacy.
- Clinical translation is hindered by these challenges.
Purpose of the Study:
- To systematically review current formulation approaches for oral probiotics.
- To summarize scalable manufacturing platforms for probiotic production.
- To critically assess these methods regarding viability, targeting, feasibility, and functional output for various diseases.
Main Methods:
- Review of advanced coating techniques (electrostatic, covalent, coordinate, bio-recognitive interactions).
- Exploration of synthetic biology-driven strain engineering.
- Summary of scalable manufacturing platforms (high-density fermentation, microfluidic encapsulation).
Main Results:
- Advanced formulations focus on functional output as the primary therapeutic driver.
- Manufacturing platforms offer different advantages and limitations concerning viability, targeting, and industrial feasibility.
- Diverse diseases like colorectal cancer (CRC), inflammatory bowel disease (IBD), metabolic disorders, and neuroinflammatory conditions are potential targets.
Conclusions:
- The convergence of multiple technological platforms will drive next-generation oral probiotic formulations.
- Intelligently engineered oral probiotics are expected to be safe, effective, and personalized therapeutics.
- These advancements pave the way for clinical adoption in precision medicine.
Related Concept Videos
01:14Scale-Up Processes
The scale-up of microbial fermentation processes is essential in industrial biotechnology, allowing the transition from laboratory-scale experiments to commercial-scale production while aiming to maintain product yield and quality. This process requires meticulous adjustment of equipment design, process parameters, and contamination control strategies to accommodate increasing culture volumes.At the laboratory scale, cultures are typically maintained in 1 to 10-liter glass or autoclavable...
01:27Upstream Processing
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
01:22Bioreactor Controls-III
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
01:30Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
01:27Production of Antibiotics
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
01:29Microbes in Food Production
Microbial fermentation is central to food biotechnology, enhancing flavor, texture, preservation, and stability. Fermentative microorganisms metabolize carbohydrates into organic acids, alcohols, and other metabolites that inhibit spoilage organisms and improve digestibility while contributing distinctive sensory qualities.In baking, amylases naturally present in flour hydrolyze starch into monosaccharides such as glucose, which Saccharomyces cerevisiae ferments anaerobically. Through...